Seller record · forhers.com

Hers

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 1 of 8 criteria. S5, analytical documentation: No certificate, lot report or test document appears in the terms, the weight loss answers, the product pages, or anywhere else on the site.

At a glance

Hersforhers.com

7/8criteria passed

Price: Wegovy pill from $149 a month, plus membership
Sells: brand Wegovy pill and pen, brand Ozempic pill and pen, and 5 more
FDA letters: 1 on file

Unpaid link. Hers does not pay the site. Funding

Visit Hers See all eight dispositions

Telehealth service. Passes 7 of 8 criteria. Recorded against Standard v1.1.

A telehealth brand selling brand GLP-1 drugs, from the Wegovy, Ozempic and Foundayo pills to Zepbound and Mounjaro, each priced monthly behind a required membership. Its terms name six filling pharmacies.

Operating entity Hims & Hers Health, Inc.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	forhers.com/weight-loss/wegovy-pill
S2	Prescription gating	PASS	forhers.com/g/i/mm-wm/your-goal
S3	Pharmacy identification	PASS	forhers.com/terms-and-conditions
S4	Compounding disclosure	PASS	forhers.com, forhers.com/weight-loss
S5	Analytical documentation	FAIL	forhers.com/sitemap.xml
S6	Business address	PASS	forhers.com/privacy-policy
S7	Price disclosure	PASS	forhers.com/weight-loss, forhers.com/weight-loss/faq
S8	Enforcement status	PASS	fda.gov, letter 716825

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA state-licensed provider reviews each patient's health history and weight loss goals to decide whether they qualify before prescribing any treatment.Source: forhers.com/weight-loss/wegovy-pill.

S2PASSThe first intake question, which asks the buyer's weight loss goal, stops the order, and the site states that medication is not available without a membership.Source: forhers.com/g/i/mm-wm/your-goal.

S3PASSSix pharmacies are named in the terms: Apostrophe Pharmacy, XeCare, EHT Pharmacy doing business as Curexa, CD Pharmacy doing business as Red Rock Pharmacy, AnazaoHealth Corporation, and Strive Specialties.Source: forhers.com/terms-and-conditions.

S4PASSCompounded products are not approved nor evaluated for safety, efficacy, or quality by the FDA, printed on the home page beneath its compounded hair products. Every weight loss drug on sale is a brand drug.Source: forhers.com, forhers.com/weight-loss.

S5FAILNo certificate, lot report or test document appears in the terms, the weight loss answers, the product pages, or anywhere else on the site.Source: forhers.com/sitemap.xml.

S6PASSHims & Hers Health, Inc. at 2269 Chestnut Street, #523, San Francisco, CA 94123, printed in the privacy policy and matching the address on its warning letter.Source: forhers.com/privacy-policy.

S7PASSThe Wegovy pill from 149 dollars a month, the Wegovy pen from 199 dollars and Zepbound from 299 dollars, plus a required membership at 39 dollars for the first month and 149 dollars a month after.Source: forhers.com/weight-loss, forhers.com/weight-loss/faq.

S8PASSFDA warning letter 716825, September 2025, names Hims & Hers Health, Inc. doing business as Hers at 2269 Chestnut St., #523, San Francisco, California, the address its own privacy policy prints, and it reviewed forhers.com. It alleges that claims for the compounded semaglutide offered there, among them the same active ingredient as Ozempic and Wegovy, are false or misleading. No compounded GLP-1 is on sale on the weight loss pages. No close-out letter appears in the index. No FDA action has halted the business, and the company continues to operate.Source: fda.gov, letter 716825.

Products shown on the seller's own pages at the recorded date: brand Wegovy pill and pen, brand Ozempic pill and pen, brand Zepbound vial and pen, brand Mounjaro, brand Foundayo pill, compounded hair loss products, birth control.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Enforcement documents on file: 1 warning letter

FDA warning letter 716825, issued September 2025, to Hims & Hers Health, Inc. dba HersClaims on forhers.com that compounded semaglutide has the same active ingredient as Ozempic and Wegovy, and clinically proven ingredients, are false or misleading.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Unpaid link. Hers does not pay the site, and nothing is earned when it is used. Funding.

Visit Hers

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.